OHSU Researchers Uncover Cellular 'Trade Winds' Driving Cancer Metastasis

The Serendipitous Discovery of Cellular Trade Winds at OHSU

Oregon Health & Science University (OHSU) researchers have unveiled a groundbreaking mechanism inside cells that challenges long-held beliefs in cell biology. During a neurobiology course at the Marine Biological Laboratory, scientists Catherine Galbraith, Ph.D., and James Galbraith, Ph.D., from OHSU's Department of Biomedical Engineering, stumbled upon an unexpected phenomenon. While using a laser to bleach proteins in a strip across a living cell's rear—a routine technique to track movement—a second dark line mysteriously appeared at the cell's front. This indicated a rapid forward wave of soluble actin proteins, far quicker than random diffusion could explain. 41 82

What followed was years of rigorous experimentation, leading to the identification of 'cellular trade winds'—directed cytoplasmic fluid flows that propel essential proteins like actin to the cell's leading edge. Published in Nature Communications on March 30, 2026, the study titled 'Compartmentalized cytoplasmic tradewinds direct soluble proteins' reveals how these flows enable efficient cell movement, wound healing, and potentially cancer spread. 82

The Galbraiths, both associate professors and Discovery Engine Investigators at the OHSU Knight Cancer Institute, collaborated with experts at the Howard Hughes Medical Institute's Janelia Research Campus. Their work highlights OHSU's role in pushing the boundaries of biomedical imaging and cancer research.

Challenging the Diffusion Paradigm in Cell Biology

For decades, textbooks described protein transport inside cells as primarily random diffusion—a Brownian motion where molecules jostle passively through the cytoplasm. However, this model couldn't account for the speed needed for dynamic processes like cell migration. The OHSU study demonstrates advection: bulk fluid movement enhancing diffusion, akin to ocean currents speeding ships. 82

These trade winds operate in a specialized 'pseudo-organelle' at the cell's lamellipodium (the leading edge sheet-like protrusion). An actin-myosin condensate barrier— a dense, vertical wall about 15 nanometers thick—compartmentalizes the cytoplasm, preventing mixing and directing flows. Contraction at the cell rear, driven by myosin motors, squeezes fluid forward, much like wringing a sponge. 41

Quantitatively, anterograde actin velocity reached 3.6 ± 1.1 μm/s—nearly 50 times faster than rearward flow—while overall cytoplasmic velocity was 1.8 μm/s in the lamella versus 1.1 μm/s in the cell body. Myosin inhibition slowed this by 2-4 fold, confirming the mechanism. 82

Revolutionary Imaging Techniques Power the Breakthrough

Visualizing these nanoscale flows required cutting-edge tools. The team invented FLOP (Fluorescence Leaving the Original Point), photoactivating fluorescent proteins at a point to track dispersion asymmetry. Combined with fluorescence correlation spectroscopy (FCS), it quantified diffusion (11.1 μm²/s lamella) and flow.

Super-resolution microscopy shone: iPALM (interferometric photoactivated localization microscopy), co-developed by the Galbraiths, provided 15 nm 3D resolution, revealing the barrier's curved structure steering flows to protrusions. 3D structured illumination microscopy (SIM) complemented this. Janelia's unique setups validated findings. 41 82

"The instrumentation we needed doesn’t exist in most places," Cathy Galbraith noted. This fusion of engineering, physics, and biology exemplifies OHSU's innovative approach. 41

How Cellular Trade Winds Work Step-by-Step

1. Barrier Formation: Actin-myosin condensate erects a dynamic wall at the lamellipodium base, creating a confined compartment.
2. Rear Contraction: Myosin II pulls actin rearward, squeezing cytoplasm forward like a conveyor.
3. Non-Specific Advection: Flow sweeps actin, Arp2/3, vinculin, paxillin—even inert probes—forward at uniform speeds.
4. Curvature Steering: Barrier arcs flatten or curve, directing flow to active protrusions.
5. Protrusion Feedback: Delivered proteins fuel lamellipodia extension, adhesion, migration.

This feedback loop synchronizes morphology and protein distribution, absent in non-migrating cells where diffusion dominates. 82

Essential Role in Wound Healing and Immune Response

Beyond migration, trade winds accelerate tissue repair. Immune cells rush to wounds, fibroblasts close gaps—both rely on rapid leading-edge protein delivery. "Cells really do ‘go with the flow,’" Jim Galbraith quipped. 41

In regenerative medicine, mimicking these flows could enhance stem cell therapies or bioengineered tissues. Synthetic biology might engineer 'wind tunnels' for precise protein targeting.

Linking Cellular Winds to Cancer Metastasis

Metastasis—the spread of cancer cells—causes about 90% of cancer deaths, with over 600,000 U.S. fatalities in 2018 alone from metastatic disease. 72 77 Invasive cancers hijack trade winds, enhancing flows for swift motility proteins delivery, evading therapies.

"We know these highly invasive cells have this really cool mechanism to push proteins really fast," Galbraith explained. Differences in barrier assembly or flow strength between normal and cancer cells offer therapeutic windows—disrupt winds in tumors without harming healthy tissue.OHSU News on the study

The Knight Cancer Institute, bolstered by a record $2 billion Knight family gift, positions OHSU to translate this into anti-metastatic drugs. 52

OHSU Knight Cancer Institute: Driving U.S. Cancer Research

OHSU's Knight Cancer Institute leads in precision oncology, CAR-T therapies, and early detection. Director Brian Druker pioneered Gleevec; recent $2B funding accelerates bold research. The Galbraiths' work aligns with Discovery Engine initiatives tackling metastasis. 52

Annually, Knight advances clinical trials and community partnerships, impacting Oregon and beyond. This study exemplifies university-driven innovation in higher education's research ecosystem.

Cancer Metastasis: A Global and U.S. Crisis

In the U.S., cancer remains a leading killer; metastasis evades primary treatments. Reviews confirm flows vs. diffusion debates, with prior studies hinting at advection but lacking visualization. 62 OHSU's nanoscale insights bridge gaps.

Stakeholders—from NCI-funded labs to biotech—eye targeting cytoskeletal dynamics. Balanced views: while promising, flows' conservation across cells demands precision to avoid side effects.

Future Outlook: Therapies, Drug Delivery, and Beyond

Small jet stream shifts alter weather; subtle trade wind tweaks could halt metastasis. Screen inhibitors of myosin or barriers; enhance for wound dressings.

"Small changes in these cellular winds could change how diseases begin or progress," Cathy Galbraith said. 41 Ongoing OHSU trials integrate this into precision medicine pipelines.

Collaborative Excellence: OHSU and Janelia Synergy

Janelia's iPALM, pioneered with Nobelist Eric Betzig, enabled 3D views. Such partnerships amplify university research, training next-gen microscopists.

In higher ed, this underscores interdisciplinary teams—biomed engineers, physicists—driving discoveries.

Photo by HI! ESTUDIO on Unsplash

Actionable Insights for Researchers and Educators

• Adopt FLOP/iPALM for motility studies.
• Explore flow inhibitors in metastasis models.
• Integrate into curricula: cell biology now includes advection.
• Fund imaging cores like OHSU's.

For faculty, /research-jobs at AcademicJobs.com lists Knight-like opportunities. Postdocs thrive via /higher-ed-career-advice/postdoctoral-success-how-to-thrive-in-your-research-role.